search

menu

  • Research Research
    • Where science meets inspired minds

    • Back
    • Research
    • Our Science
    • Research Groups
    • Facilities & Platforms
    • Clinical research
    • Find a researcher
    • Publications
    • Knowledge Transfer
  • Careers & study Careers & study
    • Become a leader in cancer research

    • Back
    • Careers & study
    • Vacancies
    • Faculty
    • Scientific staff
    • Scientific support staff
    • Postdoctoral fellows
    • PhD Students
    • Operational staff
    • Clinical fellows
    • Life in Amsterdam
    • Student internships
  • News & Events News & Events
    • Check out our stories and events

    • Back
    • News & Events
    • News
    • Media & Press
    • Calendar
  • About us About us
    • Maximum impact for cancer patients

    • Back
    • About us
    • Our vision
    • Organization
    • Collaborations
    • Responsible Research
    • Support us
    • Visit us
    • Contact us
  • Support us
Support us
  • Home
  • Publications
  • Research
  • Publications
  • Article

Neutrophils Kill Antibody-Opsonized Cancer Cells by Trogoptosis.

Hanke L Matlung ,
Liane Babes ,
Xi Wen Zhao ,
Michel van Houdt ,
Louise W Treffers ,
Dieke J van Rees ,
Katka Franke ,
Karin Schornagel ,
Paul Verkuijlen ,
Hans Janssen ,
Pasi Halonen ,
Cor Lieftink ,
Roderick L Beijersbergen ,
Jeanette H W Leusen ,
Jaap J Boelens ,
Ingrid Kuhnle ,
Jutte van der Werff Ten Bosch ,
Karl Seeger ,
Sergio Rutella ,
Daria Pagliara ,
Takashi Matozaki ,
Eiji Suzuki ,
Catharina Willemien Menke-van der Houven van Oordt ,
Robin van Bruggen ,
Dirk Roos ,
Rene A W van Lier ,
Taco W Kuijpers ,
Paul Kubes ,
Timo K van den Berg

Abstract

Destruction of cancer cells by therapeutic antibodies occurs, at least in part, through antibody-dependent cellular cytotoxicity (ADCC), and this can be mediated by various Fc-receptor-expressing immune cells, including neutrophils. However, the mechanism(s) by which neutrophils kill antibody-opsonized cancer cells has not been established. Here, we demonstrate that neutrophils can exert a mode of destruction of cancer cells, which involves antibody-mediated trogocytosis by neutrophils. Intimately associated with this is an active mechanical disruption of the cancer cell plasma membrane, leading to a lytic (i.e., necrotic) type of cancer cell death. Furthermore, this mode of destruction of antibody-opsonized cancer cells by neutrophils is potentiated by CD47-SIRPα checkpoint blockade. Collectively, these findings show that neutrophil ADCC toward cancer cells occurs by a mechanism of cytotoxicity called trogoptosis, which can be further improved by targeting CD47-SIRPα interactions.

More about this publication

Cell reports

Volume 23
Issue nr. 13
Pages 3946-3959.e6
Publication date 26-06-2018

Full text links

Publisher website (DOI) 10.1016/j.celrep.2018.05.082
Europe PubMed Central 29949776
Pubmed 29949776

Where science meets inspired minds

Contact

Plesmanlaan 121
1066CX Amsterdam

020 512 9111 communicatie@nki.nl

Quick links

  • Vacancies
  • News
  • Contact us
  • Media & Press

Follow us on

Disclaimer
Privacy statement
Cookies
Change cookie settings

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.